Novavax Inc (NASDAQ:NVAX)
| 206.82 BATS BZX Real-Time Price As of 2:53pm ET |  -14.68 / -6.63%Today’s Change | 16.41 Today|||52-Week Range 331.68 | +85.47% Year-to-Date |
Latest NVAX News | Press Releases
Today’s Trading
| Previous close | 221.50 |
| Today’s open | 218.00 |
| Day’s range | 200.03 - 222.00 |
| Volume | 79,512 |
| Average volume (3 months) | 4,200,287 |
| Market cap | $16.8B |
Data as of 2:53pm ET, 04/20/2021
Growth & Valuation
| Earnings growth (last year) | -31.99% |
| Earnings growth (this year) | +393.29% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +2,448.48% |
| P/E ratio | NM |
| Price/Sales | 13.49 |
| Price/Book | 25.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TECHBio-Techne Corp | -3.82 | -0.92% |
| ZLABZai Lab Ltd | -15.63 | -9.50% |
| BMRNBiomarin Pharmaceuti... | -0.09 | -0.11% |
| ---- |
Data as of 2:53pm ET, 04/20/2021
Financials
| Next reporting date | May 6, 2021 |
| EPS forecast (this quarter) | -$3.60 |
| Annual revenue (last year) | $475.6M |
| Annual profit (last year) | -$418.3M |
| Net profit margin | -87.94% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
